Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Well, OSCI hasn't been on the radar screen for quite a while.

The one aspect that had & still interests me intellectually perhaps more than investment wise is:

The company also has a late-stage antibiotic candidate, Ramoplanin, under investigation for the treatment of Clostridium difficile-associated disease.

Here is the Yahoo summary page for them if anyone would like to take a look.

I might also suggest you take your questions, virtuexru, to the biotech board. Here is the link:

Lots of very well schooled & smart friends there.
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.